Use of glucagon-like peptide-1 (glp-1) or analogs to abolish...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/26 (2006.01) C07K 14/605 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2263802

This invention provides a method of attenuating post-surgical catabolic changes and hormonal responses to stress. GLP-1, a GLP-1 analog, or a GLP-1 derivative, is administered at a dose effective to normalize blood glucose.

Cette invention se rapporte à un procédé d'atténuation des modifications cataboliques postopératoires et des réactions hormonales au stress. Conformément à ce procédé, on administre du GLP-1, un analogue de GLP-1 ou un dérivé de GLP-1, en quantité suffisante pour régulariser le glucose sanguin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of glucagon-like peptide-1 (glp-1) or analogs to abolish... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of glucagon-like peptide-1 (glp-1) or analogs to abolish..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of glucagon-like peptide-1 (glp-1) or analogs to abolish... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1654514

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.